Related Experiment Video
Updated: May 28, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Prophage-Derived Endolysin E1 Synergizes with Meropenem Against Acinetobacter baumannii
Jinyu Wang1, Jinlong Bai1, Yuhui Li1
1College of Life Sciences, Shihezi University, Shihezi 832003, China.
Abstract:
Carbapenem-resistant Acinetobacter baumannii (CRAB) is classified as a critical priority pathogen by the World Health Organization, and new therapeutic alternatives are urgently needed. In this study, we performed genomic mining of 27,531 A. baumannii genomes and identified 5144 prophage-derived endolysin candidates. Four highly prevalent candidates (E1-E4) were recombinantly expressed and functionally evaluated against A. baumannii. Among them, E1 exhibited the strongest bactericidal activity against reference strains ATCC 19606 and CMCC 25001, with a minimum inhibitory concentration in the micromolar range. E1 effectively disrupted preformed biofilms (>60% reduction) and remained stable under a broad range of temperatures (4-60 °C), pH values (6-8), and NaCl concentrations (up to 500 mM). Structural analysis indicated that E1 adopts a canonical lysozyme-like fold with key residues for peptidoglycan binding, and its lytic activity in vitro relied on 1 mM EDTA-mediated outer membrane permeabilization. In a murine peritoneal infection model, combination therapy with E1 and meropenem (each at 1 × MIC) significantly increased the survival rate to 66.7% and reduced bacterial loads in blood and multiple organs. This study demonstrates that prophage-derived endolysin E1 acts synergistically with meropenem against A. baumannii, supporting E1 as a promising candidate for developing combination therapies against CRAB.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA